Liquid biopsy for ctDNA to revolutionize the care of patients with early stage lung cancers

The current standard of adjuvant therapies for patients with early stage non-small-cell lung cancers largely depends on the stage of disease. Liquid biopsy for circulating tumor DNA (ctDNA) has the potential to detect minimal residual disease, depict genomic evolution, guide precision medicine to in...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Ann Transl Med
Huvudupphovsmän: Li, Bob T., Stephens, Dennis, Chaft, Jamie E., Rudin, Charles M., Jones, David R., Rusch, Valerie W., Rimner, Andreas, Isbell, James M.
Materialtyp: Artigo
Språk:Inglês
Publicerad: AME Publishing Company 2017
Ämnen:
Perspective
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5733322/
https://ncbi.nlm.nih.gov/pubmed/29285512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.09.02
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk